Blue Sage Capital has successfully exited its investment in Controlled Recovery, selling the company to R360 Treatment, which enhances CRI's growth prospects in the non-hazardous oil and gas waste management sector.
Information on the Target
Controlled Recovery, commonly referred to as CRI, is recognized as the largest facility for non-hazardous oil and gas waste management in the United States. Under the management of John Barnidge, who serves as CEO, CRI has continually expanded its capabilities and operations to meet the growing demand in this critical sector. The facility plays a pivotal role in ensuring the safe and efficient disposal and management of waste, aligning with industry standards and environmental regulations.
Blue Sage Capital has successfully exited its investment in CRI, having been the majority controlling shareholder during its tenure. This strategic decision to sell the company to R360 Treatment signals not just a profitable return for Blue Sage but also a promising future for CRI as it embarks on further growth initiatives.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The oil and gas waste management industry in the United States has seen significant growth, driven by increasing regulatory pressures and a focus on environmentally responsible practices. As companies within
Similar Deals
LS Power → BP Wind Energy North America Inc.
2025
Iron Oak Energy Solutions LLC → High Roller Sand
2025
EOG Resources, Inc. → Encino Acquisition Partners
2025
Epic Star Energy → Pacific Current
2025
Brookfield Infrastructure Partners L.P. → Colonial Enterprises
2025
R360 Treatment
invested in
Controlled Recovery (CRI)
in 2023
in a Buyout deal